Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder-Reference-Cited by-同舟云学术

Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder

Published:2016-12 Issue:14 Volume:23 Page:1699-1705
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Keefe John R^ORCID,Mao Jun J,Soeller Irene,Li Qing S,Amsterdam Jay D

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference65 articles.

1. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revision. Washington, DC: American Psychiatric Association; 476.

2. A randomized, double-blind, placebo-controlled trial of oral matricaria recutita (chamomile) extract therapy for generalized anxiety disorder;Amsterdam;J. Clin. Psychopharmacol,2009

3. The diagnosis and management of benzodiazepine dependence;Ashton;Curr. Opin. Psychiatry,2005

4. A cross-ethnic comparison of lifetime prevalence rates of anxiety disorders;Asnaani;J. Nerv. Ment. Dis.,2010

5. Benzodiazepine-like compounds and GABA in flower heads of matricaria chamomilla;Avallone;Phytoth. Res.,1995

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elaboração e implantação de um Horto medicinal em um Centro de Atenção Psicossocial Álcool e Drogas;Ciência ET Praxis;2024-08-07

2. Effect of Matricaria chamomile on morphine reward memory, the role of the serotonin receptor and CSF levels following conditional place preference in rats;Learning and Motivation;2024-08

3. Effectiveness of a virtual reality-based restorative environment on psychiatric disorders for intensive care patients: study protocol for a randomized controlled trial;2024-02-21

4. Effects of aromatherapy with Matricaria chamomile essential oil on anxiety and hemodynamic indices in patients with acute coronary syndrome, 2021: a randomized controlled trial;BMC Complementary Medicine and Therapies;2024-01-03

5. Integrative and Complementary Medicine in Psychiatry;Tasman’s Psychiatry;2024